Jamieson Wellness (TSE:JWEL) had its price objective cut by National Bank Financial from C$29.00 to C$27.00 in a report issued on Wednesday. The firm currently has an “outperform” rating on the stock. National Bank Financial’s price target suggests a potential upside of 43.24% from the stock’s current price.
Other equities research analysts have also issued research reports about the company. BMO Capital Markets lowered Jamieson Wellness from an “outperform” rating to a “market perform” rating and decreased their price target for the stock from C$28.00 to C$24.00 in a research note on Wednesday. Royal Bank of Canada boosted their price target on Jamieson Wellness from C$27.00 to C$29.00 and gave the stock an “outperform” rating in a research note on Thursday, August 9th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. Jamieson Wellness has an average rating of “Buy” and a consensus target price of C$26.60.
Shares of TSE:JWEL opened at C$18.85 on Wednesday. Jamieson Wellness has a 12 month low of C$17.15 and a 12 month high of C$27.88.
About Jamieson Wellness
Jamieson Wellness Inc develops, manufactures, distributes, sells, and markets natural health products worldwide. The company operates in two segments, Jamieson Brands and Strategic Partners. The company offers health products for humans, including vitamins, herbals, and mineral nutritional supplements; and over-the-counter remedies under the Jamieson and LVHS brands, as well as sports nutrition products under the Progressive, Precision, and Iron Vegan brands.
Read More: Tariff
Receive News & Ratings for Jamieson Wellness Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jamieson Wellness and related companies with MarketBeat.com's FREE daily email newsletter.